Amino acid replacement: P105S. This mutation is in the C terminal end the first BIR domain.
C16039676T
P105S | Diap1-PA; P105S | Diap1-PB; P105S | Diap1-PC; P105S | Diap1-PD; P105S | Diap1-PE; P105S | Diap1-PF
P105S
Site of nucleotide substitution in mutant inferred by FlyBase based on reported amino acid change.
13% of th4/th21-2s egg chambers have border follicle cell migration defects. 11% of th7/th21-2s egg chambers have border follicle cell migration defects. 14% of th5/th21-2s egg chambers have border follicle cell migration defects, 25% have extra follicle cells and 3% have more than 15 nurse cells. 3% of th5/th21-2s egg chambers show polarity defects. Less than 1% of th6B/th21-2s egg chambers have border follicle cell migration defects, while 10% have more than 15 nurse cells. 10% of th6B/th21-2s egg chambers show polarity defects. Homozygous follicle cells clones result in border follicle cell migration defects.
Diap121-2s/th[+] is an enhancer of border follicle cell phenotype of chic01320/chick13321
Diap121-2s/th[+] is an enhancer of border follicle cell phenotype of chic01320/chic221
Diap121-2s is a suppressor of phenotype of hidGMR.PG
Diap121-2s is a suppressor of phenotype of rprGMR.PW
51% of chic01320/chick13321 ; th21-2s/+ egg chambers have border follicle cell migration defects. In some egg chambers, the border follicle cells migrate to the side of the egg chamber instead of through the middle of the nurse cells, a phenotype that is never seen in wild-type egg chambers. 48% of chic01320/chic221 ; th21-2s/+ egg chambers have border follicle cell migration defects.